Sign In
Buy NRXP
$4.05
-0.570 (-12.34%)
At Close: Jun 03, 2026
Conference Begins on November 15, 2021 Conference Begins on November 15, 2021
NRx Pharma's COVID-19 Candidate Receives FDA Review For Manufacturing Information
12:15pm, Thursday, 11'th Nov 2021
NRx Pharmaceuticals Inc (NASDAQ: NRXP) has received the FDA's response to NRx's submission of updated manufacturing information for Zyesami (aviptadil). The completion of this review, without the i
Why NRX Pharmaceuticals Stock Is Jumping Today
11:55am, Thursday, 11'th Nov 2021
The company received good news from the FDA.
NRx Pharmaceuticals to Report Third Quarter 2021 Financial and Business Update on Tuesday, November 16, 2021
12:32pm, Tuesday, 09'th Nov 2021
--Company to Host Conference Call on Tuesday, November 16, 2021, at 8:30AM ET-- --Company to Host Conference Call on Tuesday, November 16, 2021, at 8:30AM ET--
NRx Pharma Stock Nosedives As FDA Strikes Off Its COVID-19 Drug Hopeful
08:30am, Friday, 05'th Nov 2021
The FDA has declined the emergency use authorization (EUA) for NRx Pharmaceuticals' (NASDAQ: NRXP) Zyesami (aviptadil). The Company is developing aviptadil in collaboration with Relief Therapeu
1 Small-Cap Stock With 10X Potential
07:45am, Wednesday, 27'th Oct 2021
This company's coronavirus efforts could pay off big time.
2 Biotech Stocks Poised for Jaw-Dropping Growth
07:45am, Sunday, 17'th Oct 2021
These two tiny drugmakers could make early shareholders wealthy.
Why NRx Pharmaceuticals Stock Is Tumbling Today
12:20pm, Friday, 15'th Oct 2021
The drugmaker is being sued by Relief Therapeutics.
GENEVA, SWITZERLAND / ACCESSWIRE / October 15, 2021 / RELIEF THERAPEUTICS Holding SA (SIX:RLF, OTCQB:RLFTF) (" Relief "), a biopharmaceutical company seeking to provide patients therapeutic relief fro
Pharma Stock Rises After Upbeat Covid Treatment Data
01:51pm, Thursday, 14'th Oct 2021
NRx Pharmaceuticals Inc (NASDAQ:NRXP) burst onto the scene today, tacking on 35.3% to trade at $12.77 at last check, following the publication of peer-reviewed results from a controlled trial of NRx's
Why NRx Pharmaceuticals Stock Is Jumping Again on Thursday
11:20am, Thursday, 14'th Oct 2021
New clinical trial results bode well for aviptadil in treating critically ill COVID-19 patients.
Why NRX Pharmaceuticals Stock Is Surging Today
10:27am, Thursday, 14'th Oct 2021
NRX Pharmaceuticals Inc (NASDAQ: NRXP) is trading significantly higher Thursday after the company announced the Journal of Infectious Diseases and Treatment published trial data of aviptadil in high
NRXP Stock: The Critical Covid-19 Trial Results That Have NRx Pharma Rocketing Higher
10:05am, Thursday, 14'th Oct 2021
NRX Pharmaceuticals (NRXP) stock is surging higher on Thursday thanks to recent results from a clinical trial of its Covid-19 treatment. The post NRXP Stock: The Critical Covid-19 Trial Results That H
RADNOR, Pa., Oct. 14, 2021 /PRNewswire/ -- NRx Pharmaceuticals (Nasdaq: NRXP), today announced the publication of peer-reviewed results from a prospective, open-label, administratively controlled tri
Are the shares of NRX Pharma making a comeback? A look at the charts
09:59am, Wednesday, 13'th Oct 2021
Shares of NRX Pharmaceuticals Inc. (NASDAQ: NRXP) spiked in price by over 60% on Tuesday due to positive news from the FDA related to their product Zyesami. This could be the return of their shares af
